Deepika Rao

Deepika Rao

Auto-generated profile, based on publicly available information

Deepika Rao

Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Health Psychology and Behavioral Medicine
Verified
Journal Article
Open access
OSOlayinka O Shiyanbola
Olayinka O Shiyanbola
DRDeepika Rao
Deepika Rao
DBDaniel Bolt
Daniel Bolt
CBCarolyn Brown
Carolyn Brown
MZMengqi Zhang
Mengqi Zhang
EWEarlise Ward
Earlise Ward
Although qualitative methods have been used to develop quantitative behavioral health measurements, studies rarely report on the exact development process of these questionnaires. In this methodolo...

1 September 2020 in Substance Abuse
Verified
Journal Article
Closed access
DRDeepika Rao
Deepika Rao
VGVincent Giannetti
Vincent Giannetti
KKKhalid M. Kamal
Khalid M. Kamal
JCJordan R Covvey
Jordan R Covvey
JTJohn R. Tomko
John R. Tomko
Background: Community pharmacists can play a meaningful role in identification and treatment of substance use disorders (SUD). However, inadequate disease knowledge and negative attitudes are known barriers. The relationship between knowledge, attitudes, and practice of pharmacists regarding persons with SUD has not been evaluated comprehensively in the United States. The objective of the study was to assess knowledge of community pharmacists regarding medications for SUD and evaluate their attitudes, levels of stigma, and clinical practices in SUD. Methods: A questionnaire was developed to assess practices, knowledge, screening services, and attitudes toward harm reduction strategies and treatment. A standardized measure of stigma was included along with demographics. A cross-sectional electronic survey was conducted in Pennsylvania, Ohio, and West Virginia among a non-probability sample of community pharmacists working for a retail pharmacy chain (n = 910) and a local alumni network ( n = 50). Scores were calculated for each factor and descriptive analyses, mean differences ( t -tests and ANOVA), correlations with demographics and practice characteristics were performed. Linear and ordinal regressions were utilized to predict knowledge, practice, screening, and stigma scores. Results: A total of 134 responses (response rate 13.9%) were collected. On average, the pharmacists were 38 years old, had worked for 15 years, primarily full-time with practice locations in suburban settings. Only 53% reported they received SUD education in pharmacy school. Pharmacists received a mean score of 5.5 and 3.5 out of eight and seven on knowledge and practice scales, respectively. Pharmacists overall had slightly stigmatizing and negative attitudes, with higher stigma significantly related to performing lesser services and considering screenings as important. Number of years worked significantly predicted knowledge and screening. Conclusion: Relationships between knowledge, attitudes, and practices indicate a need for experiential education that includes psychosocial aspects of care with increased opportunities for practice.

1 January 2022 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
DRDeepika Rao
Deepika Rao
OSOlayinka O. Shiyanbola
Olayinka O. Shiyanbola

25 August 2021 in Substance Use & Misuse
Verified
Journal Article
Closed access
DRDeepika Rao
Deepika Rao
VGVincent Giannetti
Vincent Giannetti
KKKhalid M. Kamal
Khalid M. Kamal
JCJordan R. Covvey
Jordan R. Covvey
JTJohn R. Tomko
John R. Tomko
Community pharmacists have significant opportunity to contribute to prevention and treatment of opioid use disorders, but barriers to implementation still exist. Understanding their viewpoints is c...

17 May 2023 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
DRDeepika Rao
Deepika Rao
MMMeg Mercy
Meg Mercy
CMChristine McAtee
Christine McAtee
James Ford IIJames Ford II
James Ford II
OSOlayinka O Shiyanbola
Olayinka O Shiyanbola

29 December 2023 in Substance use & addiction journal
Verified
Journal Article
Closed access
DRDeepika Rao
Deepika Rao
CMChristine McAtee
Christine McAtee
MMMeg Mercy
Meg Mercy
OSOlayinka O Shiyanbola
Olayinka O Shiyanbola
JFJames H. Ford
James H. Ford
Background: Screening and brief interventions (SBI) can help identify opioid safety risks and healthcare professionals can accordingly intervene without a significant increase in workload. Pharmacists, one of the most accessible healthcare professionals, are uniquely positioned to offer SBI. To design an effective intervention with high potential for implementation, we explored pharmacist needs and barriers regarding SBI for opioid use disorders. Methods: Using the Consolidated Framework for Implementation Research (CFIR), we conducted 11 semi-structured 60-minute interviews with community pharmacists. We used a purposeful sample of English-speaking pharmacists practicing in varied pharmacies (small independent, large-chain, specialty-retail) and positions (managers, owners, full-time/part-time pharmacists). Transcriptions were analyzed using deductive content analysis based on CFIR constructs, followed by inductive open coding. Utilizing a theoretical framework for data collection and analysis, a diverse sample of pharmacist roles, peer debriefing, and 2 independent coders for each transcript, altogether increased the credibility and transferability of our research. Data collection and analysis continued until data saturation was achieved. Results: Pharmacists described good working relationships with colleagues, organization cultures that were open to new initiatives, and believed the SBI to be compatible with their organization goals and pharmacy structure, which are facilitators for future SBI implementation. Pharmacists were motivated by improved patient outcomes, more patient interaction and clinical roles, representing facilitators at the individual level. They also described stigma toward patients, mixed need for change, and lack of knowledge regarding SBI, which are potential barriers to be addressed. Pharmacists believed that the SBI model was adaptable, not complicated, and benefits outweighed implementation costs. Conclusions: We addressed current SBI literature gaps—mainly lack of focus on implementation and contextual data, through rigorous implementation-focused qualitative research. Our exploratory findings have direct implications on future pharmacy-based SBI implementation.